The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Up 17.4% in February

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 13,500 shares, a growth of 17.4% from the February 13th total of 11,500 shares. Based on an average daily volume of 30,900 shares, the days-to-cover ratio is presently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Price Performance

NASDAQ CGABL opened at $17.88 on Thursday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 12 month low of $17.48 and a 12 month high of $20.85. The company has a 50-day moving average of $18.11 and a 200-day moving average of $18.92.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Saturday, February 15th. Investors of record on Saturday, February 1st were given a dividend of $0.2891 per share. This is a positive change from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. The ex-dividend date was Friday, January 31st. This represents a $1.16 annualized dividend and a yield of 6.47%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.